BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36604640)

  • 1. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).
    Guittet L; Quipourt V; Aparicio T; Carola E; Seitz JF; Paillaud E; Lievre A; Boulahssass R; Vitellius C; Bengrine L; Canoui-Poitrine F; Manfredi S
    BMC Cancer; 2023 Jan; 23(1):17. PubMed ID: 36604640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.
    Dinh TA; Alperin P; Walter LC; Smith R
    J Gen Intern Med; 2012 Jun; 27(6):730-8. PubMed ID: 22237663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider recommendations for colorectal cancer screening in elderly veterans.
    Kahi CJ; van Ryn M; Juliar B; Stuart JS; Imperiale TF
    J Gen Intern Med; 2009 Dec; 24(12):1263-8. PubMed ID: 19763698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Am J Gastroenterol; 2017 Jul; 112(7):1016-1030. PubMed ID: 28555630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonoscopy for colorectal cancer screening above age 75: outcomes in symptomatic african american and Hispanic adults.
    Singhal S; Verma A; Anand K
    J Gastrointest Cancer; 2011 Dec; 42(4):212-6. PubMed ID: 20635165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy.
    Lin OS; Kozarek RA; Schembre DB; Ayub K; Gluck M; Drennan F; Soon MS; Rabeneck L
    JAMA; 2006 May; 295(20):2357-65. PubMed ID: 16720821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of family history-based colorectal cancer screening in Australia.
    Ouakrim DA; Boussioutas A; Lockett T; Hopper JL; Jenkins MA
    BMC Cancer; 2014 Apr; 14():261. PubMed ID: 24735237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of screening colonoscopy on mortality in the medicare population.
    Gross CP; Soulos PR; Ross JS; Cramer LD; Guerrero C; Tinetti ME; Braithwaite RS
    J Gen Intern Med; 2011 Dec; 26(12):1441-9. PubMed ID: 21842323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
    Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
    Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.